Apolipoprotein E-epsilon 2 and Alzheimer's disease: Genotype influences pathologic phenotype
Apolipoprotein E-epsilon 2 and Alzheimer's disease: Genotype influences pathologic phenotype
复制标题
DOI:
10.1212/wnl.48.2.515
复制
发表时间:
1997-02-01
期刊:
影响因子:
9.9
通讯作者:
Roses, AD
中科院分区:
文献类型:
--
作者:
Lippa, CF;Smith, TW;Roses, AD
To determine whether apolipoprotein E epsilon 2 (APOE-epsilon 2) affects neuropathology in aging and Alzheimer's disease (AD), we compared beta-amyloid plaque (A beta P) and neurofibrillary tangle densities, neuropil thread formation, and amyloid angiopathy in five APOE-epsilon 2/3 AD patients, five APOE-epsilon 3/3 AD patients, five APOE-epsilon 2/3 control patients, and five APOE-epsilon 3/3 control patients. We examined the (frontal and parietal) neocortex, hippocampus, entorhinal cortex, and cerebellum and found A beta P densities to be lower (t = 3.121, p = 0.011) in the cortex of APOE-epsilon 2/3 AD patients than in APOE-epsilon 3/3 AD patients. Amyloid angiopathy was also less in APOE-epsilon 2/3 patients than in APOE-3/3 patients (U = 4.500, p = 0.027). Control APOE-epsilon 2/3 brains had little AD-related pathology; even our 102-year-old control case showed few A beta Ps compared with the elderly APOE-epsilon 3/3 cases. The APOE-epsilon 2/3 genotype may influence pathologic phenotype in some aged normal and AD populations.